Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV001818158 | SCV002067435 | uncertain significance | not specified | 2021-07-26 | criteria provided, single submitter | clinical testing | DNA sequence analysis of the ITGB3 gene demonstrated a sequence change, c.1297C>G, in exon 10 that results in an amino acid change, p.Pro433Ala. This sequence change has been described in the gnomAD database with frequency of 0.0046% in the non-Finnish European subpopulation (dbSNP rs121918448). The p.Pro433Ala change affects a highly conserved amino acid residue located in a domain of the ITGB3 protein that is known to be functional. The p.Pro433Ala substitution appears to be deleterious using several in-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL). This sequence change has been reported in a case of neonatal alloimmune thrombocytopenia (PMID: 8093349). Due to insufficient evidences and the lack of functional studies, the clinical significance of the p.Pro433Ala change remains unknown at this time. |
OMIM | RCV000014525 | SCV000034776 | benign | Mo ALLOANTIGEN POLYMORPHISM | 1993-01-01 | no assertion criteria provided | literature only |